Laboratory Biossafety Manual
Community Health Impact Coalition members & colleagues from across the world are sharing COVID-19 explainers, internal policies, clinical protocols, & more live
Временные рекомендации 25 января 2020 г.
How we respond both now and going forward will help mitigate the impact of COVID-19, and to the extent possible preserve children’s rights to Survive, Learn, and Be Protected. We will focus our efforts on the most critical work essential to maintaining these commitments to the extent possible.
The Table Top (TTX) COVID-19 exercise is a tool that has been developed to assist Governments and Agencies in the process of strengthening plans and policies with the intention of being able to identify and contain and outbreak of COVID19 in the country. The TTX Simulation is designed to support the... use of the “WHO Operational Readiness Benchmarks for COVID-19” (see in reference documents provided). This exercise uses the scenario of an imported case, as the base for a detailed discussion guided by the exercise facilitator.
more
revised version December 2020
Accessed on 11.03.2020
Burkina Faso will not achieve the Millennium Development Goals (MDGs) on reducing maternal mortality of children under five, which is still too high.
Strengthening the capacities of SUN Countries by sharing and disseminating good practices in the fight against malnutrition.
This report is a summary of the results of the preparation and implementation of the Learning Route (LR) organized jointly by the SUN (Scaling Up Nutrition) Movement’s S...ecretariat, the Fight Against Malnutrition Unit (CLM, Cellule de Lutte contre la Malnutrition) and PROCASUR Corporation; this Learning Route was held in Senegal from the 26th of May to the 1st of June, 2014. The aim of this publication is to illustrate the experience, its main outcomes, and the lessons learned.
more
The purpose of this document is to provide relevant information and guidelines on
coronavirus outbreaks – and in particular the novel coronavirus SARS-CoV-2 and the
diseases it produces, COVID-19 – for pharmacists and the pharmacy workforce, both in a
primary care context (i.e. community phar...macies and primary healthcare facilities) and in
hospital settings, as well as for pharmacists working as clinical biologists in medical
analysis laboratories, for example, as clinical biologists, and offer a set of references that
may be consulted for more informationstor
more
Evaluating the Return on Investment of Scaling Up Treatment for Depression, Anxiety, and Psychosis